Clinical trial

Osteosarcoma Study #2: A Randomized Trial of Pre-Surgical Chemotherapy vs…

NCT00001217 · National Cancer Institute (NCI), NIH · Completed

Key facts

NCT number NCT00001217
Title Osteosarcoma Study #2: A Randomized Trial of Pre-Surgical Chemotherapy vs. Immediate Surgery and Adjuvant Chemotherapy in the Treatment of Non-Metastatic Osteosarcoma. A Pediatric Oncology Group Phase III Study
Official title Osteosarcoma Study #2: A Randomized Trial of Pre-Surgical Chemotherapy vs. Immediate Surgery and Adjuvant Chemotherapy in the Treatment of Non-Metastatic Osteosarcoma. A Pediatric Oncology Group Phase III Study
Lead sponsor National Cancer Institute (NCI), NIH
Status Completed
Phase Phase 3
Study type Interventional
Conditions Osteosarcoma
Intervention type Drug
Interventions pre-surgical chemotherapy
Enrollment 260
Start date May 1, 1987
Completion Dec 1, 2000
First posted Dec 10, 2002
Last update posted Mar 4, 2008
Countries United States

At a glance

  • 1–9 Study sites
  • No Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies